394 related articles for article (PubMed ID: 28513646)
1. Biocompatibility and therapeutic evaluation of magnetic liposomes designed for self-controlled cancer hyperthermia and chemotherapy.
Gogoi M; Jaiswal MK; Sarma HD; Bahadur D; Banerjee R
Integr Biol (Camb); 2017 Jun; 9(6):555-565. PubMed ID: 28513646
[TBL] [Abstract][Full Text] [Related]
2. Biphasic magnetic nanoparticles-nanovesicle hybrids for chemotherapy and self-controlled hyperthermia.
Gogoi M; Sarma HD; Bahadur D; Banerjee R
Nanomedicine (Lond); 2014 May; 9(7):955-70. PubMed ID: 24102326
[TBL] [Abstract][Full Text] [Related]
3. Magnetic nanoparticles for amalgamation of magnetic hyperthermia and chemotherapy: An approach towards enhanced attenuation of tumor.
Singh A; Jain S; Sahoo SK
Mater Sci Eng C Mater Biol Appl; 2020 May; 110():110695. PubMed ID: 32204010
[TBL] [Abstract][Full Text] [Related]
4. Magnetic nanoparticle-mediated hyperthermia therapy induces tumour growth inhibition by apoptosis and Hsp90/AKT modulation.
Shetake NG; Kumar A; Gaikwad S; Ray P; Desai S; Ningthoujam RS; Vatsa RK; Pandey BN
Int J Hyperthermia; 2015; 31(8):909-19. PubMed ID: 26416812
[TBL] [Abstract][Full Text] [Related]
5. MOF-derived novel porous Fe
Xiang Z; Qi Y; Lu Y; Hu Z; Wang X; Jia W; Hu J; Ji J; Lu W
J Mater Chem B; 2020 Sep; 8(37):8671-8683. PubMed ID: 32856668
[TBL] [Abstract][Full Text] [Related]
6. Magnetic nanoparticle-based therapeutic agents for thermo-chemotherapy treatment of cancer.
Hervault A; Thanh NT
Nanoscale; 2014 Oct; 6(20):11553-73. PubMed ID: 25212238
[TBL] [Abstract][Full Text] [Related]
7. Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinoma in vivo.
Jordan A; Scholz R; Wust P; Fähling H; Krause J; Wlodarczyk W; Sander B; Vogl T; Felix R
Int J Hyperthermia; 1997; 13(6):587-605. PubMed ID: 9421741
[TBL] [Abstract][Full Text] [Related]
8. A review on hyperthermia via nanoparticle-mediated therapy.
Sohail A; Ahmad Z; Bég OA; Arshad S; Sherin L
Bull Cancer; 2017 May; 104(5):452-461. PubMed ID: 28385267
[TBL] [Abstract][Full Text] [Related]
9. Targeted hyperthermia using magnetite cationic liposomes and an alternating magnetic field in a mouse osteosarcoma model.
Shido Y; Nishida Y; Suzuki Y; Kobayashi T; Ishiguro N
J Bone Joint Surg Br; 2010 Apr; 92(4):580-5. PubMed ID: 20357339
[TBL] [Abstract][Full Text] [Related]
10. In vitro application of paclitaxel loaded magnetoliposomes for combined chemotherapy and hyperthermia.
Kulshrestha P; Gogoi M; Bahadur D; Banerjee R
Colloids Surf B Biointerfaces; 2012 Aug; 96():1-7. PubMed ID: 22521681
[TBL] [Abstract][Full Text] [Related]
11. Tumor local chemohyperthermia using docetaxel-embedded magnetoliposomes: Interaction of chemotherapy and hyperthermia.
Yoshida M; Sato M; Yamamoto Y; Maehara T; Naohara T; Aono H; Sugishita H; Sato K; Watanabe Y
J Gastroenterol Hepatol; 2012 Feb; 27(2):406-11. PubMed ID: 22098478
[TBL] [Abstract][Full Text] [Related]
12. Thermosensitive liposomal taxol formulation: heat-mediated targeted drug delivery in murine melanoma.
Sharma D; Chelvi TP; Kaur J; Ralhan R
Melanoma Res; 1998 Jun; 8(3):240-4. PubMed ID: 9664145
[TBL] [Abstract][Full Text] [Related]
13. Hyperthermia mediated liposomal drug delivery.
Ponce AM; Vujaskovic Z; Yuan F; Needham D; Dewhirst MW
Int J Hyperthermia; 2006 May; 22(3):205-13. PubMed ID: 16754340
[TBL] [Abstract][Full Text] [Related]
14. Magnetic nanoparticle hyperthermia enhances radiation therapy: A study in mouse models of human prostate cancer.
Attaluri A; Kandala SK; Wabler M; Zhou H; Cornejo C; Armour M; Hedayati M; Zhang Y; DeWeese TL; Herman C; Ivkov R
Int J Hyperthermia; 2015 Jun; 31(4):359-74. PubMed ID: 25811736
[TBL] [Abstract][Full Text] [Related]
15. Magnetoliposomes of mixed biomimetic and inorganic magnetic nanoparticles as enhanced hyperthermia agents.
Jabalera Y; Fernández-Vivas A; Iglesias GR; Delgado ÁV; Jimenez-Lopez C
Colloids Surf B Biointerfaces; 2019 Nov; 183():110435. PubMed ID: 31430636
[TBL] [Abstract][Full Text] [Related]
16. Magnetic nanoparticle-induced hyperthermia with appropriate payloads: Paul Ehrlich's "magic (nano)bullet" for cancer theranostics?
Datta NR; Krishnan S; Speiser DE; Neufeld E; Kuster N; Bodis S; Hofmann H
Cancer Treat Rev; 2016 Nov; 50():217-227. PubMed ID: 27756009
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of magnetic hyperthermia performance and biocompatibility of magnetite and novel Fe-doped hardystonite nanoparticles for potential bone cancer therapy.
Farzin A; Hassan S; Emadi R; Etesami SA; Ai J
Mater Sci Eng C Mater Biol Appl; 2019 May; 98():930-938. PubMed ID: 30813100
[TBL] [Abstract][Full Text] [Related]
18. Development and Assessment of Nano-Technologies for Cancer Treatment: Cytotoxicity and Hyperthermia Laboratory Studies.
Medina-Ramírez IE; Díaz de León Olmos MA; Muñoz Ortega MH; Zapien JA; Betancourt I; Santoyo-Elvira N
Cancer Invest; 2020 Jan; 38(1):61-84. PubMed ID: 31791151
[TBL] [Abstract][Full Text] [Related]
19. Gadolinium-doped iron oxide nanoparticles induced magnetic field hyperthermia combined with radiotherapy increases tumour response by vascular disruption and improved oxygenation.
Jiang PS; Tsai HY; Drake P; Wang FN; Chiang CS
Int J Hyperthermia; 2017 Nov; 33(7):770-778. PubMed ID: 28540811
[TBL] [Abstract][Full Text] [Related]
20. Heat-activated thermosensitive liposomal cisplatin (HTLC) results in effective growth delay of cervical carcinoma in mice.
Dou YN; Zheng J; Foltz WD; Weersink R; Chaudary N; Jaffray DA; Allen C
J Control Release; 2014 Mar; 178():69-78. PubMed ID: 24440663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
